
浏览全部资源
扫码关注微信
中部战区总医院骨科,湖北 武汉 430070
夏平光,E-mail:xiapg@sina.com
收稿日期:2024-10-13,
纸质出版日期:2025-09-25
移动端阅览
夏平光,蒋翔,张宝成.自体骨复合同种异体骨修复膝周骨巨细胞瘤微波原位灭活后骨缺损的效果[J].局解手术学杂志,2025,34(09):795-799.
XIA Ping-guang,JIANG Xiang,ZHANG Bao-cheng.Effect of autologous bone and allogeneic bone in repair of bone defect after microwave in situ inactivation for bone giant cell tumor around the knee[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(09):795-799.
夏平光,蒋翔,张宝成.自体骨复合同种异体骨修复膝周骨巨细胞瘤微波原位灭活后骨缺损的效果[J].局解手术学杂志,2025,34(09):795-799. DOI: 10.11659/jjssx.10E024040.
XIA Ping-guang,JIANG Xiang,ZHANG Bao-cheng.Effect of autologous bone and allogeneic bone in repair of bone defect after microwave in situ inactivation for bone giant cell tumor around the knee[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2025,34(09):795-799. DOI: 10.11659/jjssx.10E024040.
目的
2
探讨自体骨复合同种异体骨修复膝周骨巨细胞瘤微波原位灭活后骨缺损的临床效果。
方法
2
回顾性分析我院2015年1月至2022年12月收治的39例膝周骨巨细胞瘤患者的临床资料。先用微波原位灭活肿瘤组织,再予以刮除,然后用自体骨重建软骨下骨邻近的骨缺损,剩下的瘤腔采用自体骨与同种异体骨混合植骨,再用锁定钢板进行保护性固定。记录患者手术时间、术中出血量、住院时间、切口愈合及手术相关并发症等早期结果。术后定期随访,观察肿瘤复发、转移情况,记录内固定情况、植骨融合情况及其时间。术前及末次随访时采用国际骨肿瘤协会(MSTS)评分系统对膝关节功能进行评价。末次随访时采用Aboulafia分级系统对影像学关节退变进行评定。
结果
2
患者手术时间平均(134.7±14.2)min,术中出血量平均(153.9±23.0)mL,住院时间平均(17.4±3.2)d。术后患者切口均Ⅰ期愈合,无神经血管损伤等手术相关并发症发生。患者术后均获得随访,随访期间无肿瘤局部复发及转移。末次随访时患者MSTS评分高于术前(
P
<
0.05),术后膝关节功能恢复优良率为89.7%。末次随访时X射线片显示病灶填充良好、植骨融合,融合时间平均(9.4±2.1)个月;未出现关节面塌陷、骨折等。Aboulafia分级显示0级20例,1级11例,2级8例。
结论
2
膝周骨巨细胞瘤微波原位灭活后用自体骨复合同种异体骨修复肿瘤刮除后的骨缺损,膝关节功能恢复理想,并可有效防止关节面塌陷和退变,有助于瘤腔重建。
Objective
2
To investigate the clinical effect of autologous bone combined with allogeneic bone in repairing bone defect after microwave in situ inactivation for bone giant cell tumor around the knee.
Methods
2
A retrospective analysis was conducted on the clinical data of 39 patients with bone giant cell tumor around the knee treated in our hospital from January 2015 to December 2022. The tumor tissues of all patients were performed microwave in situ inactivation first, then followed by curettage; the subchondral bone defect adjacent to the articular surface was reconstructed with autologous bone graft, and the remaining tumor cavity was filled with a composite of autologous and allogeneic bone; then a locking plate was applied for protective fixation. The early outcomes including operative time, intraoperative blood loss, hospital stay, wound healing, and surgery-related complications were recorded. The regular follow-up was conducted after surgery, then the tumor recurrence or metastasis was observed and the status of internal fixation and bone graft fusion along with its fusion time were recorded. The knee functions before operation and at the end of follow-up were evaluated with the Musculoskeletal Tumor Society (MSTS) scoring system. The radiographic joint degeneration was evaluated by the Aboulafia classification system at the end of follow-up.
Results
2
The patients showed a mean operative time of (134.7±14.2)minutes, an averaged intraoperative blood loss of (153.9±23.0)mL, and a mean hospital stay of (17.4±3.2)days. The patients obtained Ⅰ phase wound healing without any surgery-related complications such as neurovascular injury. All patients underwent the postoperative follow-up, without local recurrence or metastasis cases during the follow-up. At the end of follow-up, the MSTS score of patients was higher than that before operation(
P
<
0.05), with an excellent and good rate of knee function recovery of 89.7%. At the end of follow-up,X-ray films showed good filling of the lesion and bone graft fusion, with a mean fusion time of (9.4±2.1)months.No collapse or fracture of the articular surface occurred. According to the Aboulafia classification, there were 20 cases of grade 0, 11 cases of grade 1, and 8 cases of grade 2.
Conclusion
2
The autologous bone and allogeneic bone in repair of bone defect after microwave in situ inactivation for bone giant cell tumor around the knee has perfect knee function recovery, and can effectively prevent the collapse and degeneration of articular surfaces,which helps in the reconstruction of tumor cavity.
van der Heijden L , Dijkstra S , van de Sande M , et al . Current concepts in the treatment of giant cell tumour of bone [J]. Curr Opin Oncol , 2020 , 32 ( 4 ): 332 - 338 . doi: 10.1097/CCO.0000000000000645 http://dx.doi.org/10.1097/CCO.0000000000000645 .
Montgomery C , Couch C , Emory CL , et al . Giant cell tumor of bone: review of current literature, evaluation, and treatment options [J]. J Knee Surg , 2019 , 32 ( 4 ): 331 - 336 . doi: 10.1055/s-0038-1675815 http://dx.doi.org/10.1055/s-0038-1675815 .
Yu XC , Xu M , Song RX , et al . Long-term outcome of giant cell tumors of bone around the knee treated by en bloc resection of tumor and reconstruction with prosthesis [J]. Orthop Surg , 2010 , 2 ( 3 ): 211 - 217 . doi: 10.1111/j.1757-7861.2010.00089.x http://dx.doi.org/10.1111/j.1757-7861.2010.00089.x .
Colangeli S , Del Chiaro A , Andreani L , et al . Giant cell tumor of extremities, surgical treatment and local adjuvants: which is the most effective? [J]. J Biol Regul Homeost Agents , 2020 , 34 (5 Suppl 1 ): 57 - 62 .
Lin X , Liu J , Xu M . The prognosis of giant cell tumor of bone and the vital risk factors that affect its postoperative recurrence: a meta-analysis [J]. Transl Cancer Res , 2021 , 10 ( 4 ): 1712 - 1722 . doi: 10.21037/tcr-20-3100 http://dx.doi.org/10.21037/tcr-20-3100 .
Jiang X , Chen J , Zhou W , et al . Microwave in situ inactivation in the treatment of bone giant cell tumor: a mid-term descriptive study [J]. J Cancer Res Clin Oncol , 2023 , 149 ( 8 ): 4653 - 4661 . doi: 10.1007/s00432-022-04348-9 http://dx.doi.org/10.1007/s00432-022-04348-9 .
Aboulafia AJ , Rosenbaum DH , Sicard-Rosenbaum L , et al . Treatment of large subchondral tumors of the knee with cryosurgery and composite reconstruction [J]. Clin Orthop Relat Res , 1994 ( 307 ): 189 - 199 .
郭卫 , 李建民 , 沈靖南 , 等 . 骨巨细胞瘤临床循证诊疗指南 [J]. 中华骨与关节外科杂志 , 2018 , 11 ( 4 ): 276 - 287 . doi: 10.3969/j.issn. 2095-9958.2018.04.004 http://dx.doi.org/10.3969/j.issn.2095-9958.2018.04.004 .
Lans J , Oflazoglu K , Lee H , et al . Giant cell tumors of the upper extremity: predictors of recurrence [J]. J Hand Surg Am , 2020 , 45 ( 8 ): 738 - 745 . doi: 10.1016/j.jhsa.2020.04.020 http://dx.doi.org/10.1016/j.jhsa.2020.04.020 .
Tsukamoto S , Mavrogenis AF , Hindiskere S , et al . Outcome of reoperation for local recurrence following en bloc resection for bone giant cell tumor of the extremity [J]. Curr Oncol , 2022 , 29 ( 9 ): 6383 - 6399 . doi: 10.3390/curroncol29090503 http://dx.doi.org/10.3390/curroncol29090503 .
Soares do Brito J , Spranger A , Almeida P , et al . Giant cell tumour of bone around the knee: a systematic review of the functional and oncological outcomes [J]. EFORT Open Rev , 2021 , 6 ( 8 ): 641 - 650 . doi: 10.1302/2058-5241.6.200154 http://dx.doi.org/10.1302/2058-5241.6.200154 .
Ke J , Cheng S , Yao MY , et al . Novel strategy of curettage and adjuvant microwave therapy for the treatment of giant cell tumor of bone in extremities: a preliminary study [J]. Orthop Surg , 2021 , 13 ( 1 ): 185 - 195 . doi: 10.1111/os.12865 http://dx.doi.org/10.1111/os.12865 .
Zheng K , Yu X , Hu Y , et al . Clinical guideline for microwave ablation of bone tumors in extremities [J]. Orthop Surg , 2020 , 12 ( 4 ): 1036 - 1044 . doi: 10.1111/os.12749 http://dx.doi.org/10.1111/os.12749 .
Zheng K , Yu XC , Xu M , et al . Conservative surgery with microwave ablation for recurrent bone tumor in the extremities: a single-center study [J]. BMC Cancer , 2022 , 22 ( 1 ): 1122 . doi: 10.1186/s12885-022-10233-y http://dx.doi.org/10.1186/s12885-022-10233-y .
Machak GN , Snetkov AI . The impact of curettage technique on local control in giant cell tumour of bone [J]. Int Orthop , 2021 , 45 ( 3 ): 779 - 789 . doi: 10.1007/s00264-020-04860-y http://dx.doi.org/10.1007/s00264-020-04860-y .
Zheng C , Xu G , Zhou X , et al . Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center [J]. J Orthop Surg Res , 2024 , 19 ( 1 ): 488 . doi: 10.1186/s13018-024-04981-9 http://dx.doi.org/10.1186/s13018-024-04981-9 .
Cui H , Li J , Zheng K , et al . Microwave-assisted intralesional curettage combined with other adjuvant methods for treatment of Campanacci Ⅲ giant cell tumor of bone in distal radius: a multicenter clinical study [J]. Front Oncol , 2024 , 14 : 1383247 . doi: 10.3389/fonc. 2024.1383247 http://dx.doi.org/10.3389/fonc.2024.1383247 .
Li J , Guo Z , Wang Z , et al . Does microwave ablation of the tumor edge allow for joint-sparing surgery in patients with osteosarcoma of the proximal tibia? [J]. Clin Orthop Relat Res , 2015 , 473 ( 10 ): 3204 - 3211 . doi: 10.1007/s11999-015-4447-y http://dx.doi.org/10.1007/s11999-015-4447-y .
Vaishya R , Pokhrel A , Agarwal AK , et al . Current status of bone cementing and bone grafting for giant cell tumour of bone: a systemic review [J]. Ann R Coll Surg Engl , 2019 , 101 ( 2 ): 79 - 85 . doi: 10.1308/rcsann.2019.0004 http://dx.doi.org/10.1308/rcsann.2019.0004 .
曹武 , 叶招明 , 林秾 , 等 . 膝关节周围骨巨细胞瘤刮除后填充骨水泥对关节软骨影响的临床研究 [J]. 中国修复重建外科杂志 , 2014 , 28 ( 12 ): 1459 - 1463 . doi: 10.7507/1002-1892.20140316 http://dx.doi.org/10.7507/1002-1892.20140316 .
Benevenia J , Rivero SM , Moore J , et al . Supplemental bone grafting in giant cell tumor of the extremity reduces nononcologic complications [J]. Clin Orthop Relat Res , 2017 , 475 ( 3 ): 776 - 783 . doi: 10.1007/s11999-016-4755-x http://dx.doi.org/10.1007/s11999-016-4755-x .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621